Van ECK Associates Corp Acquires 18,035 Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Van ECK Associates Corp grew its holdings in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 68.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 44,556 shares of the company’s stock after acquiring an additional 18,035 shares during the period. Van ECK Associates Corp owned about 0.12% of Crescent Capital BDC worth $819,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Sun Life Financial Inc. raised its stake in Crescent Capital BDC by 20.7% during the third quarter. Sun Life Financial Inc. now owns 2,226,308 shares of the company’s stock worth $41,187,000 after buying an additional 382,542 shares during the last quarter. Millennium Management LLC grew its holdings in Crescent Capital BDC by 31.9% in the second quarter. Millennium Management LLC now owns 268,097 shares of the company’s stock worth $5,035,000 after purchasing an additional 64,902 shares during the period. Condor Capital Management grew its holdings in Crescent Capital BDC by 12.4% in the second quarter. Condor Capital Management now owns 252,121 shares of the company’s stock worth $4,735,000 after purchasing an additional 27,801 shares during the period. International Assets Investment Management LLC acquired a new stake in Crescent Capital BDC in the third quarter worth $1,899,000. Finally, Hennion & Walsh Asset Management Inc. grew its holdings in Crescent Capital BDC by 90.3% in the third quarter. Hennion & Walsh Asset Management Inc. now owns 94,182 shares of the company’s stock worth $1,742,000 after purchasing an additional 44,700 shares during the period. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Stock Down 0.4 %

Crescent Capital BDC stock opened at $18.22 on Tuesday. Crescent Capital BDC, Inc. has a fifty-two week low of $15.91 and a fifty-two week high of $19.63. The stock has a market cap of $675.23 million, a PE ratio of 6.63 and a beta of 0.81. The firm’s 50-day simple moving average is $18.38 and its 200 day simple moving average is $18.39. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.40 and a current ratio of 1.40.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings data on Monday, August 12th. The company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.58 by $0.01. The business had revenue of $48.95 million for the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a net margin of 51.61% and a return on equity of 12.03%. During the same quarter in the previous year, the firm posted $0.56 earnings per share. Research analysts predict that Crescent Capital BDC, Inc. will post 2.35 EPS for the current fiscal year.

Crescent Capital BDC Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th were given a $0.42 dividend. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.09. The ex-dividend date was Monday, September 30th. This represents a $1.68 annualized dividend and a yield of 9.22%. Crescent Capital BDC’s payout ratio is currently 61.09%.

Analyst Ratings Changes

A number of research firms have commented on CCAP. LADENBURG THALM/SH SH started coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 price target for the company. Wells Fargo & Company reduced their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Wednesday, August 14th. Finally, Bank of America reduced their price objective on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $19.00.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.